Bone cysts are fluid-filled or blood-filled cavities that develop inside bone, weakening it from within and sometimes causing pain or fractures. Most are benign, but the word “cyst” still alarms people when it shows up on an imaging report. The reality is that bone cysts come in several distinct types, each with its own cause, behavior, and treatment path, and understanding which kind you or your child is dealing with changes everything about what happens next.
The Main Types of Bone Cysts
When doctors talk about bone cysts, they are usually referring to one of a few specific lesions. The two most commonly discussed in orthopedic practice are unicameral (simple) bone cysts and aneurysmal bone cysts, but subchondral bone cysts and intraosseous ganglion cysts also fall under the umbrella. Each behaves differently, arises from a different process, and shows up in different patients.
A simple bone cyst, also called a unicameral bone cyst (UBC), is a single fluid-filled cavity inside bone. It may be one smooth chamber or partially divided. An aneurysmal bone cyst (ABC) is an expansive, blood-filled lesion that tends to be multicameral, meaning it has multiple compartments separated by walls of tissue. ABCs characteristically bulge outward from the bone and can appear in virtually any bone in the skeleton.1PubMed. Bone cysts: unicameral and aneurysmal bone cyst Subchondral bone cysts form just beneath the cartilage surface of a joint, usually in the context of osteoarthritis. Intraosseous ganglion cysts are rare, benign cavities filled with mucoid material, most often found in middle-aged adults rather than children.2PubMed Central. A Unique Technique for Precise Targeting in Treatment of Rare Bifocal Intraosseous Ganglion Cysts of the Talus
Who Gets Bone Cysts
Simple bone cysts are overwhelmingly a pediatric problem. Roughly 85% occur in children and adolescents, and they tend to be most aggressive in the first decade of life, with recurrence rates in younger children about four times higher than in teenagers.3PubMed Central. Unicameral bone cysts: Current concepts They favor the upper arm bone (proximal humerus) and thighbone (proximal femur) in growing children, and younger children tend to have “active” lesions that sit right next to the growth plate, while older children’s cysts migrate away from it and may divide into multiple chambers.
Aneurysmal bone cysts also lean young, most commonly appearing in the first two decades of life, but they can occur at any age and in any bone. Subchondral cysts, by contrast, are typically an adult problem tied to joint wear. Intraosseous ganglion cysts peak in the fourth and fifth decades of life and are rare in children.2PubMed Central. A Unique Technique for Precise Targeting in Treatment of Rare Bifocal Intraosseous Ganglion Cysts of the Talus
What Causes Each Type
Simple Bone Cysts
The exact cause of simple bone cysts remains debated. The prevailing view is that they result from a disruption in normal bone growth and remodeling near the growth plate, leading to a fluid-filled cavity that slowly expands and thins the surrounding bone over time.3PubMed Central. Unicameral bone cysts: Current concepts Because they tend to appear adjacent to the physis (the growth plate) in young, actively growing children, many researchers suspect a localized blockage of fluid drainage during bone development. The fact that they often become less active and even resolve spontaneously after skeletal maturity supports the idea that growth-related processes are central to their formation.
Aneurysmal Bone Cysts
ABCs have a clearer genetic story. Research has identified specific chromosomal rearrangements involving a gene called USP6 as the driving force behind most primary ABCs. Various translocations swap the USP6 gene next to an unrelated gene’s promoter, essentially hijacking that promoter to crank up USP6 expression.4PubMed. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes The discovery of these USP6 fusion genes reshaped how scientists understand ABCs, moving them from “mysterious reactive lesions” to neoplasms with a recognizable molecular mechanism.5PubMed. USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis
Recent work has added an interesting wrinkle: many of the genes that partner with USP6 in these fusions are normally active during tissue repair. This has led to an emerging concept that ABCs may be a type of “tissue repair-associated neoplasm,” where the fusion creates a cell primed to proliferate, and a repair-like environment in the bone triggers that proliferation to begin.6PubMed Central. Novel and unusual USP6 fusion partners in aneurysmal bone cyst and their role in pathogenesis and histopathological evaluation of this disease It is worth noting that ABCs can also arise secondarily within other bone tumors, in which case they are a reactive phenomenon rather than a primary lesion.
Subchondral Bone Cysts
Subchondral cysts form by a different process entirely, one tied to joint degeneration. One leading theory holds that as articular cartilage wears thin in osteoarthritis, repeated mechanical loading creates microfractures at the junction between cartilage and bone. Synovial fluid then penetrates through those cracks into the subchondral bone, setting off an inflammatory response and forming a cyst-like cavity filled with myxomatous tissue.7PubMed Central. Subchondral Bone Cyst Development in Osteoarthritis: From Pathophysiology to Bone Microarchitecture Changes and Clinical Implementations These cysts are closely linked to osteoarthritis severity and tend to enlarge as joint disease progresses.
How Bone Cysts Present
Many bone cysts produce no symptoms at all and are discovered incidentally when an X-ray is taken for an unrelated reason. A child might break a bone during a normal activity, and the resulting imaging reveals a cyst that weakened the bone to the point of fracture. This is called a pathological fracture, and for simple bone cysts in children it is often the very first sign that anything is wrong.
Aneurysmal bone cysts are more likely to announce themselves with pain, sometimes accompanied by a palpable lump or visible deformity if the cyst has expanded substantially. Pathological fractures occur in roughly 8% of ABCs overall, though the rate can climb as high as 21% when the cyst involves the spine.8PubMed Central. Pathological Fractures in Aneurysmal Bone Cysts: A Systematic Review Spinal ABCs can also cause neurological symptoms by compressing the spinal cord or nerve roots, which makes them particularly concerning.
Subchondral cysts typically present as part of the larger picture of joint pain in osteoarthritis. The cyst itself may contribute to pain through changes in local pressure and bone architecture, but it can be hard to separate its symptoms from the surrounding joint disease. Intraosseous ganglion cysts often cause a dull ache around a joint, particularly the ankle or wrist, but they too can be entirely silent.
How Bone Cysts Are Diagnosed
Plain X-rays are usually the starting point. A simple bone cyst typically shows up as a well-defined, centrally located lucent area in the metaphysis (the flared portion near the end of a long bone). An ABC tends to appear as an eccentric, expansive lesion with a well-defined sclerotic border and a blown-out but intact cortex.9International Journal of Musculoskeletal Disorders. Is Fluid- Fluid Level in Osseous Lesions- A Diagnostic Clue?
MRI is the most sensitive tool for evaluating bone cysts in detail, partly because it can reveal fluid-fluid levels, which are layers of different-density fluids settling inside the cyst. These levels are characteristic of ABCs, but they are not exclusive to them. The same finding can appear in other lesions, including some malignant tumors, so fluid-fluid levels alone are not enough to make a definitive diagnosis.10PubMed. Fluid-fluid Levels in Musculoskeletal Tumor Imaging The full picture, combining imaging features, patient age, location, and sometimes a biopsy, is what clinicians use to reach the right answer.
Why Getting the Diagnosis Right Matters
One of the genuine dangers in bone cyst diagnosis is mistaking a malignant tumor for a benign cyst, or vice versa. The most worrisome mimic is telangiectatic osteosarcoma, an aggressive cancer that can look remarkably similar to an aneurysmal bone cyst on imaging. Both appear as destructive, blood-filled lesions with fluid-fluid levels. The distinguishing features can be subtle: telangiectatic osteosarcoma tends to have thicker, more nodular walls and septa, a wider zone of transition, and cortical destruction extending into surrounding soft tissues. On MRI, areas of high signal on certain sequences suggest the presence of old blood products, and careful inspection may reveal dark areas between the fluid levels that are not typical of a benign ABC.11Journal of Clinical Orthopaedics and Trauma. Cystic bone Lesions: Diagnostic pitfalls and therapeutic considerations Even under the microscope, telling these two apart can be challenging. This is why any aggressive-looking cystic bone lesion, particularly in an unusual location or with atypical features, warrants careful evaluation and often a biopsy before treatment begins.
Treating Simple Bone Cysts
Because many simple bone cysts are discovered after a fracture, the first step is often just treating the fracture itself and watching the cyst. A significant number of UBCs will shrink or resolve on their own after the fracture heals, especially in older children approaching skeletal maturity. When a cyst persists, is actively expanding, or is in a location at high risk for fracture (like the femoral neck, where a break could have serious consequences), intervention is usually recommended.
The most common minimally invasive approach involves injecting something into the cyst cavity after aspirating the fluid. Steroid injection, typically methylprednisolone acetate, has been used for decades. In one study, steroid injections produced satisfactory results in about 81% of patients, with complete healing in roughly 62% and partial healing in another 19%.12PubMed Central. Steroid Injection and Biomarker Levels in the Treatment of Unicameral Bone Cysts: Can we Estimate the Result? However, multiple injection sessions are often needed, and recurrence remains a real possibility.
Autologous bone marrow injection, where bone marrow is drawn from the patient’s pelvis and injected into the cyst, has gained traction as an alternative. A decision analysis comparing treatment strategies for simple bone cysts found that bone marrow injection had the highest expected value among all approaches, slightly edging out steroid injection, observation alone, decompression, and curettage with bone grafting.13PubMed Central. Determining the best treatment for simple bone cyst: a decision analysis Combining bone marrow concentrate with demineralized bone matrix has shown even stronger results. One comparative study found an 83% success rate with this combination versus about 59% with steroid injections alone at a minimum of two years follow-up.14PubMed Central. Treatment of simple bone cyst with bone marrow concentrate and equine-derived demineralized bone matrix injection versus methylprednisolone acetate injections
When cysts are large, recurrent, or located in structurally critical areas, surgical curettage (scraping out the cyst lining) followed by bone grafting may be necessary. Percutaneous curettage, performed through a small incision, paired with local bone graft has been reported to produce healing without recurrence over an average follow-up of more than six years in one series treating both simple and aneurysmal bone cysts.15PubMed Central. Percutaneous Curettage and Local Autologous Cancellous Bone Graft: A Simple and Efficient Method of Treatment for Benign Bone Cysts
Treating Aneurysmal Bone Cysts
ABCs are traditionally managed with extended curettage and bone grafting, sometimes augmented with an adjuvant like phenol or cement to reduce the chance of recurrence. But the trend in recent years has been toward less invasive options when the lesion’s size and location permit it.
Sclerotherapy, which involves injecting a sclerosing agent like polidocanol directly into the cyst under image guidance, has emerged as a first-line option for many ABCs. In one series of 38 consecutive patients treated with repeated polidocanol injections, the method was effective in 97% of cases, with only a single patient requiring open surgery.16PubMed Central. Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts: Good results in 37 of 38 consecutive patients Another study of 26 patients reported complete bone filling in over 92% and significant pain reduction, with two recurrences successfully retreated with additional injections.17PubMed Central. Sclerotherapy for Aneurysmal Bone Cyst: A Single-Center Experience A systematic review confirmed that sequential polidocanol instillations reduce cyst volume and minimize recurrence, though results vary and some patients do need multiple sessions.18PubMed Central. Sclerotherapy with polidocanol as a treatment for aneurysmal bone cyst: A systematic review
The appeal of sclerotherapy is that it avoids the morbidity of open surgery, can be repeated easily, and preserves bone stock. The downside is that it often requires several treatment sessions spaced weeks or months apart, and the response can be slow. For ABCs in locations where the structural integrity of the bone is an immediate concern, or where the cyst is compressing the spinal cord, surgery may still be the best first move.
Denosumab and Emerging Therapies for Difficult ABCs
For ABCs that keep coming back, are destroying critical structures, or sit in places where surgery would carry high morbidity, like the spine or pelvis, denosumab has shown promise. This drug, which blocks a signaling molecule involved in bone resorption, is already used for other bone conditions. Early case series in ABC patients have reported meaningful clinical and radiological improvement, with favorable side-effect profiles.19PubMed. Denosumab treatment in aneurysmal bone cyst: Evaluation of nine cases Researchers have suggested it could serve as a treatment option especially in spinal and pelvic ABCs where surgical risk is high, or as a way to shrink a cyst before surgery to make the operation safer.20PubMed Central. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results These are still preliminary results from small series, not large randomized trials, so denosumab is not yet standard care for ABCs, but it is an increasingly recognized option when conventional approaches fail.
Recurrence and What Drives It
Recurrence is the central frustration in bone cyst management. For simple bone cysts, younger age is the strongest predictor. Cysts in the first decade of life recur about four times as often as those in adolescents, likely because the growing physis is more actively contributing to cyst formation and maintenance.3PubMed Central. Unicameral bone cysts: Current concepts
For aneurysmal bone cysts, age again matters. Patients aged 12 or younger have a higher recurrence rate, and cysts located directly adjacent to an open growth plate are at particular risk. In one study, recurrence occurred in 8 out of 19 juxtaphyseal cysts sitting next to an active physis, while gender, race, and cyst size did not predict recurrence.21PubMed Central. Aneurysmal bone cysts recur at juxtaphyseal locations in skeletally immature patients The proximity to growing cartilage appears to create a microenvironment that favors cyst re-formation, which aligns with the tissue-repair-associated neoplasm concept described earlier.
Recurrence is not necessarily a treatment failure in the catastrophic sense. Many recurrences are successfully retreated with repeat injections or sclerotherapy. The important thing is consistent follow-up imaging, especially in younger patients, so that a recurrence is caught early before it weakens the bone again.
When Bone Cysts Threaten the Growth Plate
In children, a bone cyst near the growth plate raises a specific concern beyond fracture risk. Active cysts that abut the physis can grow through it into the epiphysis, the rounded end of the bone that forms the joint surface. This has the potential to damage the growth plate itself, leading to growth arrest. Depending on where and how much of the physis is affected, the consequences can range from a slight angular deformity of the limb to a meaningful difference in leg lengths.22Journal of Pediatric Orthopaedics. Unicameral Bone Cysts: Treatment Rationale and Approach This is one of the situations where proactive treatment is recommended even if the cyst itself is not causing symptoms, because the cost of waiting and allowing physeal damage is high. An ABC in contact with an active growth plate also carries a higher recurrence rate, compounding the challenge.23PubMed Central. Restoration of Limb Length Discrepancy and Alignment With the Ilizarov Device After Management of an Aneurysmal Bone Cyst Crossing the Distal Femoral Physis
Subchondral Cysts and Joint Disease
Subchondral bone cysts occupy a different clinical world from the cysts discussed above. They are a feature of osteoarthritis, not a standalone pediatric problem. You will sometimes hear them called “bone marrow lesions” on MRI reports, and they tend to get larger and more painful as the arthritis worsens. Because the underlying driver is joint degeneration, treating the cyst in isolation does not fix the joint.
That said, targeted treatment of subchondral cysts has gained interest as a bridge strategy. Subchondroplasty, a procedure where calcium phosphate bone substitute is injected into the cyst or bone marrow lesion under fluoroscopic guidance, has been explored as a way to relieve pain and delay the need for joint replacement. One study described it as a feasible temporizing measure that may help younger patients delay knee replacement while retaining function.24PubMed Central. Knee subchondroplasty for management of subchondral bone cysts: a novel treatment method A larger prospective study found durable pain relief at two years, with over 92% of treated knees avoiding additional surgery during that period.25PubMed Central. Calcium-Phosphate Subchondroplasty Provides Durable 24-Month Pain Relief and >90% Surgery-free Survivorship for Tibiofemoral Bone Marrow Lesions in Mild-To-Moderate Knee Osteoarthritis Subchondroplasty is not a cure for osteoarthritis, and it is not a substitute for joint replacement when the joint has deteriorated enough to need one. But for people with mild-to-moderate disease and a painful bone marrow lesion, it can buy meaningful time.
Recovery and Activity After Treatment
How quickly you return to normal activity depends on the type of cyst, its location, and the treatment used. For simple bone cysts in a lower extremity bone, clinicians typically allow full weight-bearing within one to four weeks of treatment, depending on the cyst’s size. Sports and high-impact activities are generally cleared once the cyst has healed completely, which averaged about five and a half months in one study.26PubMed Central. Treatment outcomes of the simple bone cyst: A comparative study of 2 surgical techniques using artificial bone substitutes Upper-extremity cysts, particularly in the humerus, tend to allow earlier return to daily activities since the arm does not bear body weight, but contact sports and heavy lifting still require caution until imaging confirms healing.
For ABCs treated with sclerotherapy, the process can be slow. Multiple injection sessions over months are common, and each visit resets the activity restrictions to some degree. Patients treated with open curettage and grafting follow a more conventional surgical recovery, including a period of protected weight-bearing while the graft incorporates. In all cases, follow-up imaging at regular intervals is essential, both to confirm that the bone is filling in and to catch any recurrence early. Children in particular need ongoing monitoring through the remainder of their growth, since cysts near the growth plate can reactivate or cause delayed growth disturbances even after apparently successful treatment.